IRCT20200325046854N2
Completed
Phase 2
Evaluation of efficacy and safety of colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19: a randomized clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with the common type of Novel Coronavirus Pneumonia (NCP) (at high risk) and other severe cases of newly diagnosed coronavirus pneumonia between the ages of 18 and 85 with an increase in IL\-6 levels if the patient or his or her judge agrees to participate. Study and after signing the informed consent entered the study. Definition of clinical cases of the novel Coronavirus Pneumonia (NCP) :. 1\. Specifications with NCP (with serious risk factors): Contains lung lesions based on common clinical signs of NCP with or without fever. 2\. NCP critical patient.
Exclusion Criteria
- •1\. Patients participating in other clinical studies 2\. Pregnant or lactating women; 3\. Patients receiving immunomodulatory drugs to prevent graft rejection or other cases; 4\. Allergy to any of the drug compounds; 5\. Patients with active pulmonary tuberculosis, with specific bacterial and fungal infections; Patients with malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillatioAtrial Fibrillation.Unspecified atrial fibrillationI48.91IRCT20200328046886N6Mazandaran University of Medical Sciences172
Recruiting
Phase 2
Efficacy of Colchicine in Treatment of Covid-19Covid 19.Coronavirus as the cause of diseases classified elsewhereB97.2IRCT20201229049872N1Artesh University of Medical Sciences80
Recruiting
Phase 2
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
Recruiting
Phase 3
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
Active, not recruiting
Phase 1
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1Recurrent aphthous stomatitis (RAS)EUCTR2006-003327-36-GBGuy's & St Thomas' NHS Foundation Trust136